Class IITerminated in FDA datasetRecall initiated Sep 9, 2025

Lifted Made-Lemon, Chewable tablet. 20mg 7OH/550mg Tablet-no shelf-life. Dosage: 2 doses per…

Recalling firm: Eden¿¿¿s Elixirs, LLC

Why it was recalled

Undeclared Yellow #5

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: May 15, 2026.

Check your package

Compare the exact product and package details with the label you have.

ProductLifted Made-Lemon, Chewable tablet. 20mg 7OH/550mg Tablet-no shelf-life. Dosage: 2 doses per tablet. Route of administration: oral. Shipping or unit package 10,000 or less per bulk bag. Bulk package and is not sold directly to consumer.

FDA code information

Lot Code: F250129, Packing Code: 250023 Lot Code: F250150, Packing Code: 250147 Lot Code: F250166, Packing Code: 250156

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Lifted Made-Lemon, Chewable tablet. 20mg 7OH/550mg Tablet-no shelf-life. Dosage: 2 doses per tablet. Route of administration: oral. Shipping or unit package 10,000 or less per bulk bag. Bulk package and is not sold directly to consumer.

Extracted codes and context

TypeCode / valueContext
lotF250129Lot Code: F250129, Packing Code: 250023 Lot Code: F250150, Packing Code: 250147 Lot Code: F250166, Packing Code: 250156
lotF250150Lot Code: F250129, Packing Code: 250023 Lot Code: F250150, Packing Code: 250147 Lot Code: F250166, Packing Code: 250156
lotF25016650129, Packing Code: 250023 Lot Code: F250150, Packing Code: 250147 Lot Code: F250166, Packing Code: 250156

Original FDA recall reason

Undeclared Yellow #5

Recall details

Recall number
H-0129-2026
Event ID
97593
FDA status
Terminated
Initiated
Sep 9, 2025
Reported
Oct 15, 2025
Classified
Oct 23, 2025
Terminated
May 15, 2026
Quantity
284,354 tablets
Location
Louisville, CO, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

Distributed in Texas.

FDA source record · H-0129-2026

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.